Related references
Note: Only part of the references are listed.Inhibition of dihydrotestosterone synthesis in prostate cancer by combined frontdoor and backdoor pathway blockade
Michael V. Fiandalo et al.
Oncotarget (2018)
Characterization of Prostate Cancer in a Functional Eunuch
John J. Stocking et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)
A mathematical model of microbial folate biosynthesis and utilisation: implications for antifolate development
J. Enrique Salcedo-Sora et al.
MOLECULAR BIOSYSTEMS (2016)
Androgen biosynthesis in castration-resistant prostate cancer
Trevor M. Penning
ENDOCRINE-RELATED CANCER (2014)
Safety, tolerability and anti-tumour activity of the androgen biosynthesis inhibitor ASP9521 in patients with metastatic castration-resistant prostate cancer: multi-centre phase I/II study
Yohann Loriot et al.
INVESTIGATIONAL NEW DRUGS (2014)
Androgenic biomarker profiling in human matrices and cell culture samples using high throughput, electrospray tandem mass spectrometry
John H. Wilton et al.
PROSTATE (2014)
Molecular Pathways: Inhibiting Steroid Biosynthesis in Prostate Cancer
Roberta Ferraldeschi et al.
CLINICAL CANCER RESEARCH (2013)
Steroidogenic Enzyme AKR1C3 Is a Novel Androgen Receptor-Selective Coactivator that Promotes Prostate Cancer Growth
Muralimohan Yepuru et al.
CLINICAL CANCER RESEARCH (2013)
A Mathematical Model of Tryptophan Metabolism via the Kynurenine Pathway Provides Insights into the Effects of Vitamin B-6 Deficiency, Tryptophan Loading, and Induction of Tryptophan 2,3-Dioxygenase on Tryptophan Metabolites
Luisa Rios-Avila et al.
JOURNAL OF NUTRITION (2013)
Activation of the Androgen Receptor by Intratumoral Bioconversion of Androstanediol to Dihydrotestosterone in Prostate Cancer
James L. Mohler et al.
CANCER RESEARCH (2011)
Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
Changmeng Cai et al.
CANCER RESEARCH (2011)
Potential Prostate Cancer Drug Target: Bioactivation of Androstanediol by Conversion to Dihydrotestosterone
James L. Mohler et al.
CLINICAL CANCER RESEARCH (2011)
Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants
Elahe A. Mostaghel et al.
CLINICAL CANCER RESEARCH (2011)
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. De Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer
Kai-Hsiung Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Phase II Study of Dutasteride for Recurrent Prostate Cancer During Androgen Deprivation Therapy
Satyan K. Shah et al.
JOURNAL OF UROLOGY (2009)
Mathematics for understanding disease
R. R. Bies et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven
Gerhardt Attard et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A mathematical model of glutathione metabolism
Michael C. Reed et al.
THEORETICAL BIOLOGY AND MEDICAL MODELLING (2008)
Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer
MA Titus et al.
CLINICAL CANCER RESEARCH (2005)
Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5α-reductase inhibitor
RV Clark et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
The androgen axis in recurrent prostate cancer
JL Mohler et al.
CLINICAL CANCER RESEARCH (2004)
The backdoor pathway to dihydrotestosterone
RJ Auchus
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2004)
Characterization of a novel type of human microsomal 3α-hydroxysteroid dehydrogenase -: Unique tissue distribution and catalytic properties
SV Chetyrkin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Further characterization of human microsomal 3α-hydroxysteroid dehydrogenase
SV Chetyrkin et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2001)
Share Paper
